title: Proposed diagnostic criteria for neurocysticercosis.
abstract: Neurocysticercosis is the most common helminthic infection of the CNS but its diagnosis remains difficult. Clinical manifestations are nonspecific, most neuroimaging findings are not pathognomonic, and some serologic tests have low sensitivity and specificity. The authors provide diagnostic criteria for neurocysticercosis based on objective clinical, imaging, immunologic, and epidemiologic data. These include four categories of criteria stratified on the basis of their diagnostic strength, including the following: 1) absolute--histologic demonstration of the parasite from biopsy of a brain or spinal cord lesion, cystic lesions showing the scolex on CT or MRI, and direct visualization of subretinal parasites by funduscopic examination; 2) major--lesions highly suggestive of neurocysticercosis on neuroimaging studies, positive serum enzyme-linked immunoelectrotransfer blot for the detection of anticysticercal antibodies, resolution of intracranial cystic lesions after therapy with albendazole or praziquantel, and spontaneous resolution of small single enhancing lesions; 3) minor--lesions compatible with neurocysticercosis on neuroimaging studies, clinical manifestations suggestive of neurocysticercosis, positive CSF enzyme-linked immunosorbent assay for detection of anticysticercal antibodies or cysticercal antigens, and cysticercosis outside the CNS; and 4) epidemiologic--evidence of a household contact with Taenia solium infection, individuals coming from or living in an area where cysticercosis is endemic, and history of frequent travel to disease-endemic areas. Interpretation of these criteria permits two degrees of diagnostic certainty: 1) definitive diagnosis, in patients who have one absolute criterion or in those who have two major plus one minor and one epidemiologic criterion; and 2) probable diagnosis, in patients who have one major plus two minor criteria, in those who have one major plus one minor and one epidemiologic criterion, and in those who have three minor plus one epidemiologic criterion.
authors.affiliation: Department of Neurology, Hospital-Clinica Kennedy, Guayaquil, Ecuador. odbrutto@telconet.net
authors.forename: O H
authors.initials: OH
authors.lastname: Del Brutto
authors.forename: V
authors.initials: V
authors.lastname: Rajshekhar
authors.forename: A C
authors.initials: AC
authors.lastname: White
authors.forename: V C
authors.initials: VC
authors.lastname: Tsang
authors.forename: T E
authors.initials: TE
authors.lastname: Nash
authors.forename: O M
authors.initials: OM
authors.lastname: Takayanagui
authors.forename: P M
authors.initials: PM
authors.lastname: Schantz
authors.forename: C A
authors.initials: CA
authors.lastname: Evans
authors.forename: A
authors.initials: A
authors.lastname: Flisser
authors.forename: D
authors.initials: D
authors.lastname: Correa
authors.forename: D
authors.initials: D
authors.lastname: Botero
authors.forename: J C
authors.initials: JC
authors.lastname: Allan
authors.forename: E
authors.initials: E
authors.lastname: Sarti
authors.forename: A E
authors.initials: AE
authors.lastname: Gonzalez
authors.forename: R H
authors.initials: RH
authors.lastname: Gilman
authors.forename: H H
authors.initials: HH
authors.lastname: García
mesh_terms: D006801:Humans; D020019:Neurocysticercosis / Q000175:diagnosis*